Defects of DNA mismatch repair in human prostate cancer.
about
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancerThe convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancerSingle nucleotide polymorphisms in DNA repair genes and prostate cancer riskPopulation-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.Gemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed.Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer.A rhodium(III) complex for high-affinity DNA base-pair mismatch recognitionComplex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancerFunctional role of DNA mismatch repair gene PMS2 in prostate cancer cells.A novel approach for characterizing microsatellite instability in cancer cells.Hereditary prostate cancer as a feature of Lynch syndrome.DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In Vivo.High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registryComparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines.Frequent mismatch-repair defects link prostate cancer to Lynch syndromeChromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.Implication of DNA repair genes in prostate tumourigenesis in Indian males.Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy.Chloroethylating and methylating dual function antineoplastic agents display superior cytotoxicity against repair proficient tumor cells.Elevated risk of prostate cancer among men with Lynch syndrome.Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death.Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival.A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer.The genomic landscape of prostate cancerThe genomic evolution of human prostate cancer.Immunotherapy of Prostate Cancer: Facts and Hopes.Association between the hMSH2 IVS12-6 T>C polymorphism and cancer risk: A meta-analysis.The genomic landscape of prostate cancer.MSH2 Loss in Primary Prostate Cancer.Mismatch repair enzyme expression in primary and castrate resistant prostate cancer.
P2860
Q26739708-2102B79E-FE82-4DDB-9493-58BC948F5D5DQ27014101-3BBFEC76-073C-4146-8EF6-6DB456501BB2Q28383002-0BF5743E-4BFF-4115-B24F-5A00B7AAA8B3Q30493284-CA75B9C9-F0CC-49DD-9FC6-8BAA82C1E0E0Q33414629-E08AF3AD-7615-40C2-9705-A006976819C6Q33578400-3E1E2C2E-7462-4C86-9A56-7AA4A9DD707BQ33621410-BAF5181B-E13F-4938-A6FB-D5F202072DA2Q34180274-8668A640-DD1F-4C59-AC9F-1576EF346BE4Q34252397-4FB962BC-7542-42B0-81FA-84663DD9275CQ34478988-C0DA6FE3-30EA-493B-9F2C-70CC9290F3AFQ34720965-F6F00225-80D3-4653-BA39-23EABE82544BQ34952659-04A5ED87-1585-4D3B-9CD0-61E56B1964ADQ34956579-3AA17ADD-77DC-4397-B2D4-37298F92DAF0Q34999154-E737C6DA-297D-4AFC-A3F6-D9CFCF74648EQ35085756-E3CE23B8-7F37-4C34-8162-0905307D765EQ35108540-46433418-E8E5-499E-A8B2-986CC6781EF7Q35969934-9B264DD2-106B-4260-8DBA-815ACFF2A615Q36193912-A28A99F6-1C63-44D4-9541-E46047924EDDQ36449988-55291F00-A609-4E24-BB9A-7E26CB2A1914Q36671241-D971CEDD-B520-4D0B-A8D6-4BB7A8BF8D45Q36674877-7982B17E-5DC2-4CE2-8EFF-00051FEDF78AQ36810712-C2D50C8E-BE14-4F4F-B4FE-E35BCF17F5BCQ37120640-1A2A9871-A128-481C-8849-E8CAE37F682EQ37304321-4BDF5702-D524-4712-888E-3CA8034C6461Q37701535-9C496DA1-35F1-4A78-863D-314C9A0D11D1Q38109474-682D9197-99BC-4B2B-BDDD-938E71D73101Q38540636-E6D77E72-6CF5-4DA4-A877-E590AB784BD6Q38664882-F8548529-401B-4498-866C-68021D3A01A1Q42073570-854580E7-498A-4377-9040-947516519B1EQ42174920-7E80258C-8724-4EBA-B913-57CAC1B796D6Q47976701-B96AB49F-B27C-4602-8E2B-16CF1B0A2E2CQ51789451-98E4CD49-F3A4-4807-96C9-326FDA68616C
P2860
Defects of DNA mismatch repair in human prostate cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Defects of DNA mismatch repair in human prostate cancer.
@en
Defects of DNA mismatch repair in human prostate cancer.
@nl
type
label
Defects of DNA mismatch repair in human prostate cancer.
@en
Defects of DNA mismatch repair in human prostate cancer.
@nl
prefLabel
Defects of DNA mismatch repair in human prostate cancer.
@en
Defects of DNA mismatch repair in human prostate cancer.
@nl
P2093
P1433
P1476
Defects of DNA mismatch repair in human prostate cancer
@en
P2093
C W Schweinfest
D K Watson
N K Bissada
W R Turner
P304
P407
P577
2001-05-01T00:00:00Z